First Reported Case of Reversible Cerebral Vasoconstriction Syndrome After a SARS-CoV-2 Vaccine

This is the first report of reversible cerebral vasoconstriction syndrome (RCVS) as a complication of a SARS-CoV-2 vaccination. A 38-year-old female developed visual impairment due to scotomas and thunderclap headache 18 days after the second shot of the Moderna SARS-CoV-2 vaccine. Multimodal cerebr...

Descripción completa

Detalles Bibliográficos
Autor principal: Finsterer, Josef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716124/
https://www.ncbi.nlm.nih.gov/pubmed/34987889
http://dx.doi.org/10.7759/cureus.19987

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716124/
https://www.ncbi.nlm.nih.gov/pubmed/34987889
http://dx.doi.org/10.7759/cureus.19987

Ejemplares similares